Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Charles River Laboratories
CRO
Charles River launches strategic review, shakes up board
The review comes as the CRO's revenue declined 1.8% year over year in the first quarter.
Darren Incorvaia
May 7, 2025 11:14am
Chinese CRO expands in US as industry weighs FDA animal shift
Apr 20, 2025 2:50pm
Pfizer, Flagship turn to autoimmune for latest angle of collab
Apr 1, 2025 9:38am
Charles River and Valo pact nets preclinical lupus asset
Mar 26, 2025 6:30am
Charles River cuts staff at Tennessee cell therapy site
Feb 19, 2025 2:33pm
Conduit taps Charles River to build AZ asset’s autoimmune cred
Feb 13, 2025 12:51pm
